Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Receivables: 2016-2025

Historic Change in Receivables for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to $456,916.

  • cbdMD's Change in Receivables rose 505.16% to $456,916 in Q3 2025 from the same period last year, while for Sep 2025 it was $439,565, marking a year-over-year increase of 347.14%. This contributed to the annual value of $439,565 for FY2025, which is 347.14% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's Change in Receivables is $456,916, which was up 639.08% from -$84,759 recorded in Q2 2025.
  • cbdMD's Change in Receivables' 5-year high stood at $1.0 million during Q1 2021, with a 5-year trough of -$815,369 in Q2 2022.
  • For the 3-year period, cbdMD's Change in Receivables averaged around $48,394, with its median value being $47,771 (2024).
  • Its Change in Receivables has fluctuated over the past 5 years, first spiked by 13,544.47% in 2021, then plummeted by 11,957.77% in 2022.
  • Quarterly analysis of 5 years shows cbdMD's Change in Receivables stood at -$4,554 in 2021, then plummeted by 11,957.77% to -$549,111 in 2022, then soared by 87.77% to -$67,169 in 2023, then surged by 530.16% to $288,936 in 2024, then spiked by 505.16% to $456,916 in 2025.
  • Its Change in Receivables was $456,916 in Q3 2025, compared to -$84,759 in Q2 2025 and -$221,528 in Q1 2025.